PVSS Home

Peripheral Vascular Surgery Society

 

 

#22 THIAMINE (VITAMIN B1) PROTECTS AGAINST HIGH GLUCOSE AND INSULIN MEDIATED PROLIFERATION OF HUMAN INFRAGENICULAR ARTERIAL SMOOTH MUSCLE CELLS.

Ricardo Avena, MD, Subodh Arora, MD, Brennan J. Carmody, MD, Kenyatta Cosby, BS, and Anton N. Sidawy, MD

Veterans Administration Medical Center, Washington, D.C.

Objective: Accelerated proliferation of vascular smooth muscle cell (VSMC) plays an important role in the development of atherosclerosis which preferentially affects the infragenicular vasculature in patients with diabetes mellitus. High insulin and glucose levels, which are present in patients with type II diabetes, have an additive effect in infragenicular VSMC proliferation in-vitro. Thiamine is a co-enzyme important in intracellular glucose metabolism. The objective of this study is to determine the effect of Thiamine on human infragenicular VSMC proliferation induced by high glucose and insulin levels in-vitro.

Methods: Human infragenicular VSMC isolated from diabetic patients undergoing lower extremity amputation were used. Cells were cultured at 37°C in 5% CO2. Cells were identified as VSMC by immunohistochemical analysis. Cells from passages 3-5 were exposed to glucose concentrations of 0.1% and 0.2% with and without insulin concentrations of 100 ng/ml and 1000 ng/ml, in the presence or absence of 200 mM of Thiamine. Standard hemocytometry and 3H-thymidine incorporation quantified cell proliferation after incubation for 6 days and 24 hours, respectively.

Results: Cell count and DNA synthesis, as reflected by 3H-thymidine incorporation, significantly increased in all cell groups growing in glucose concentration of 0.1% with insulin of 1000 ng/ml and in all groups growing in 0.2% glucose with and without insulin (*=p<0.05). This proliferation effect was inhibited by Thiamine (+=p<0.05).

Conclusions: These data suggest that thiamin inhibits human infragenicular VSMC proliferation induced by high glucose and insulin. Vitamin B1 intake may prove important in delaying the atherosclerotic complications of diabetes.

Return to Program

Last Updated 5/28/99